Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Acute lung injury (ALI) affects over 10% of patients hospitalised in critical care, with acute respiratory distress syndrome (ARDS) being the most severe form of ALI and having a mortality rate in the region of 40%. There has been slow but incremental progress in identification of biomarkers that contribute to the pathophysiology of ARDS, have util...
Alternative Titles
Full title
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d5508b30b55f4dfd85402c80bcae5107
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d5508b30b55f4dfd85402c80bcae5107
Other Identifiers
ISSN
1476-9255
E-ISSN
1476-9255
DOI
10.1186/s12950-018-0202-y
